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Measurement of renal blood flow by 
phase-contrast magnetic resonance 
imaging during septic acute kidney 
injury: a pilot investigation
Prowle et al., Crit Care Med 2012; 40: 1768–1776; doi:10.1097/
CCM.0b013e318246bd85
Sepsis is the most common precipitating factor in the develop-
ment of in-hospital acute kidney injury (AKI). Only a minority of 
renal biopsies show tubular necrosis, with sloughing and tubular 
obstruction; the majority show minimal histological changes on 
light microscopy. This led to the concept that sepsis-associated AKI 
was a type of vasomotor nephropathy, due to loss of renal autoregu-
lation with corresponding changes in global or regional intrarenal 
blood flow. This concept was supported by clinical studies report-
ing improved renal function with potent vasoconstrictors, such as 
norepinephrine. Imaging studies in the intensive care setting are 
typically limited to color flow Doppler studies, with initial reports 
linking increased total renal blood flow to increased cardiac out-
put with low-dose dopamine. Prowle and colleagues were able to 
perform cine phase-contrast magnetic resonance imaging measure-
ment of renal blood flow and cardiac output (Figure). As expected, 
patients with sepsis-associated AKI had increased cardiac output 
and reduced systemic vascular resistance. However, global renal 
blood flow was reduced in comparison with controls with AKI, with 
a marked reduction in relative renal blood flow to total cardiac out-
put. There was a positive correlation between renal vascular and sys-
temic vascular resistance, in keeping with the clinical observations 
of studies using vasoconstrictor agents to improve renal function, 
and bedside ultrasound Doppler measurements of renal resistivity 
index, which may be a feature of volume unresponsive or the main-
tenance phase of AKI. The dissociation between total renal blood 
flow and glomerular filtration rate in septic AKI suggests either 
significant intrarenal shunting of blood supply, or major changes 
in intraglomerular perfusion, secondary to differential changes in 
the pre- and postglomerular arteriolar resistances or elevation of the 
Bowman’s space pressure, and intraglomerular pressure resulting in 
a fall in glomerular ultrafiltration pressure gradient disproportional 
to the overall change in total renal blood flow.
This new technique may potentially allow assessment of the effect 
of pharmacologically increasing renal perfusion on glomerular 
filtration and thus may provide novel insights into protecting the 
kidney during septic AKI.
Andrew Davenport
New fibrate use and acute renal 
outcomes in elderly adults:  
a population-based study
Zhao et al., Ann Intern Med 2012; 156: 560–569
Management of the hyperlipidemia of chronic kidney disease 
(CKD) patients remains an important component of their overall 
care. This is particularly true with older patients and patients with 
high-grade proteinuria, in whom statins are often not tolerated or 
are insufficient. There has been a concern for some time that fibrate 
therapy may adversely affect kidney function, especially in older 
patients—an issue addressed by Zhao and colleagues. In their pop-
ulation-based cohort study in elderly adults within 90 days of start-
ing fibrate therapy for hyperlipidemia, they found that compared 
with ezetimibe users (n = 61,831), fibrate users (n = 19,072) were 
more likely to be hospitalized for an increase in serum creatinine 
(adjusted odds ratio 2.4, 95% confidence interval (CI) 1.7–3.3) and 
to consult a nephrologist (absolute risk difference 0.15%, 95% CI 
0.01–0.29%; adjusted odds ratio 1.3, 95% CI 1.0–1.6). There were 
no differences between groups in the risk of all-cause mortality or 
receiving dialysis for severe acute kidney injury. In a sub-popula-
tion of 1110 patients (fibrates, n = 220; ezetimibe, n = 890), 9.1% 
of fibrate users and only 0.3% of ezetimibe users had an increase 
in serum creatinine level of more than 50% (absolute difference 
8.8%, 95% CI 4.5–13.1%; odds ratio 29.6, 95% CI 8.7–100.5). Risks 
were greater among fibrate users with known preexisting CKD. The 
authors concluded that starting fibrate therapy in elderly adults was 
associated with an increase in serum creatinine and a small 90-day 
absolute increase in hospitalizations and nephrologist consultations. 
There was no detectable effect on need for dialysis, severe acute 
kidney injury, or mortality. The mechanism and clinical significance 
of the increase in serum creatinine with fibrates are still unclear.
Although the study is limited by its retrospective nature, it 
deserves attention given the increasing age of our CKD population 
and the still common usage of fibrates, especially in patients who 
do not tolerate statins. The lack of direct effect on kidney function 
Measurement of renal blood flow using cine phase-contrast 
magnetic resonance imaging. (a and b) Scout images to localize renal 
artery. (c and d) Sagittal anatomical (c) and phase-contrast (d) images.  
(e and f) Flow profile of defined region of interest, constructed over a 
cine sequence representing one heartbeat.
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with ezetimibe is also of interest given that it may be a viable and 
safer option in this population. A prospective study would obvi-
ously be more convincing.
Daniel Cattran
Calcium-sensing receptor insertion 
into plasma membrane
Grant et al., Sci Signal [online] 2011; 4: ra78; doi:10.1126/scisignal.2002208
The calcium-sensing receptor (CaSR), a G protein–coupled 
receptor (GPCR), transits through the cell from the endoplasmic 
reticulum to the plasma membrane. It operates in the constant 
presence of Ca2+, its main agonist, sensing small changes with 
high cooperativity and minimal functional desensitization. It 
regulates signaling cascades via various heterotrimeric G proteins 
and induces changes in membrane lipids, protein kinase phos-
phorylation, monomeric G protein activation state, and intracel-
lular second messengers. Grant et al. examined in more detail 
the factors that regulate the life cycle of the CaSR under ‘physi-
ological’ conditions in human embryonic kidney (HEK) 299 cells. 
They used multiwavelength total internal reflection fluorescence 
microscopy to demonstrate that the signaling properties of the 
CaSR result mainly from agonist-driven maturation and inser-
tion of CaSRs into the plasma membrane. They further showed 
that plasma membrane CaSRs undergo constitutive endocytosis 
without substantial recycling but with direct targeting to lyso-
somal degradation, in contrast to many other recycling GPCRs. 
Ongoing CaSR signaling results from agonist-driven traffick-
ing of CaSR through the secretory pathway. The intracellular 
reservoir of CaSRs that can be mobilized by agonist is depleted 
when glycosylation of newly synthesized receptors is blocked, 
suggesting that receptor biosynthesis is coupled to signaling. 
There is a continuous, signaling-dependent insertion of CaSRs 
into the plasma membrane, with minute-to-minute variations. 
This previously unknown mechanism, termed ‘agonist-driven 
insertional signaling’ (ADIS) (Figure), ensures a rapid response 
to alterations of extracellular Ca2+ or allosteric agonist despite 
ongoing desensitization and endocytosis. Although the present 
work has shortcomings, including CaSR overexpression in an 
established cell line and use of extremely high Ca2+ concentra-
tions, ADIS could represent a previously unknown adaptation of 
the canonical GPCR signaling paradigm. It would allow CaSRs to 
operate in the chronic presence of extracellular Ca2+ and translate 
small fluctuations in Ca2+ or allosteric modulators into appropri-
ate cellular responses. How ADIS relates to altered CaSR expres-
sion in various pathological states remains to be seen.
Tilman B. Drüeke
Risk factors for the hemolytic uremic 
syndrome in children infected with 
Escherichia coli O157:H7:  
a multivariable analysis
Wong et al., Clin Infect Dis advance online publication, 19 March 2012, 
doi:10.1093/cid/cis299
Hemolytic uremic syndrome (HUS) is a disease characterized by 
endothelial injury and subsequent formation of thrombosis in 
microvessels, developing the triad of thrombocytopenia, mechani-
cal hemolytic anemia, and acute kidney injury. The main cause of 
HUS is a gastrointestinal infection with toxin-producing Escheri-
chia coli such as O157:H7. Although antibiotics are effective in 
eliminating E. coli, they may also promote toxin release from E. 
coli, raising a concern about precipitation to HUS. A prospective 
cohort study by Wong et al. enrolled children infected with E. coli 
O157:H7 within one week of the onset of diarrhea in the United 
States. Of the 259 children analyzed, 36 (14%) developed HUS. 
Univariate analysis demonstrated that children who received anti-
biotics during the diarrhea phase developed HUS more frequently 
than those who did not, independently of the class of antibiotic 
used. In multivariable analysis, exposure to antibiotics during the 
first week of onset of illness was independently associated with 
development of HUS (adjusted odds ratio 3.62, 95% CI 1.23–10.6). 
In contrast, Nitschke et al. recently reported the results of a study 
of 65 patients with toxin-producing E. coli O104:H4 infection in 
Germany.1 The subjects were mainly adults and were treated a 
relatively long time after the initial symptoms. The study found 
no signs of HUS induction due to azithromycin therapy; however, 
the subjects were long-term carriers (>28 days) of E. coli O104:H4. 
Although the results clearly showed that oral azithromycin may 
be used safely for decolonization of E. coli O104:H4 carried long-
term, we cannot interpret the data as indicating the successful 
prevention of HUS in early-phase patients, who are the most likely 
to develop HUS subsequently.
In their study, Wong and colleagues have confirmed and 
extended their previous findings,2 concluding that antibiotic use 
during E. coli O157:H7 infections is associated with a higher rate 
of subsequent HUS and should be avoided. 
Masaomi Nangaku
1JAMA 2012; 307: 1046–1052. 2N Engl J Med; 342: 1930–1936.
Agonist-driven insertional signaling (ADIS) model for the calcium-
sensing receptor. Calcium-sensing receptors (CaSRs) travel to the 
plasma membrane (PM) through the secretory pathway (according to 
the rate constants k1 and k2), are activated by extracellular Ca
2+, and 
then desensitize and are endocytosed and targeted to the lysosome for 
degradation (according to the rate constant k3). Rates of transition from the 
endoplasmic reticulum (ER) to the Golgi (k1) and from the Golgi or trans-
Golgi network (TGN) to the PM (k2), but not from the PM to the lysosome 
(k3), are increased by signaling initiated by PM CaSRs. 
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